Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
Clinical trial NCT01301833 · COMPLETED
Trial details
- NCT number
- NCT01301833
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-09-01
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.